The Q&A session is guided by questions we received from you, our audience. Watch the experts discuss these, and other important topics.
Please take a moment to complete the feedback form after viewing.
This program is designed for global hematologists and all healthcare professionals managing AA patients.
Aplastic anemia (AA) is a rare hematologic disease characterized by a reduced production of blood cells. Significant advances in treatment options have been made, but there are associated complications. The disease burden remains high, and quality of life is often substantially compromised, but early diagnosis can dramatically improve patient outcomes.
This independent educational program aims to raise awareness among healthcare professionals and highlight advances in the diagnosis, treatment, and management of patients with AA that have the potential to improve patients’ outcomes and quality of life.
Our program at-a-glance
60 min webcast
Program Director and Chair Prof Régis Peffault de Latour is joined by Dr Alicia Rovó and Dr Phillip Scheinberg.
|The importance of a quick and accurate diagnosis||Prof Régis Peffault de Latour||Treatment options for patients with AA||Dr Alicia Rovó||Clinical cases||Dr Phillip Scheinberg||Discussion and Q&A||All|
Specialist Center location finder
Find aplastic anemia expertise in your area.
This independent content was supported by an educational grant from Pfizer.
Sign up now and you will be sent a link when the onDemand video is available.